The goal of this clinical trial is to study the effects of an experimental (not Food and Drug Administration (FDA)-approved) treatment called corneal crosslink…

KeratoconusEctasia of CorneaPellucid Marginal Corneal Degeneration+1 more

~Estimated

~$10 – $7,500

Woolfson Eye InstituteNCT07124910

Phase 1

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Conditions

To determine whether the Peschke PXL-330 system is safe and effective in the treatment of corneal thinning conditions.

Keratoconus, UnstableBacterial KeratitisEctasia of Cornea

~Estimated

~$10 – $7,500

Pacific Clear Vision InstituteNCT03918408